STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8
Clinical trials for STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare uterine cancer
Disease control OngoingThis study compares a new two-drug combination (olaparib and temozolomide) to the usual chemotherapy for people with advanced uterine leiomyosarcoma that has continued to grow after initial treatment. The goal is to see if the new combination can shrink or stabilize the cancer lo…
Matched conditions: STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New drug combo shows promise for Hard-to-Treat sarcomas
Disease control OngoingThis study tests whether combining two drugs—cabozantinib and temozolomide—can help people with advanced soft tissue sarcomas (like leiomyosarcoma) that have spread or can't be removed by surgery. About 96 participants will receive the combination to see if it slows tumor growth.…
Matched conditions: STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC